Ompared Arqt Us03969k1088 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ompared arqt us03969k1088. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ompared Arqt Us03969k1088 Today - Breaking & Trending Today

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

Study met both co-primary endpoints and all secondary endpointsAt week eight, 67.3% of individuals treated with roflumilast foam achieved Scalp-Investigator Global Assessment Success compared to. | September 26, 2022 ....

United States , Eric Mcintyre , Amanda Sheldon , Exchange Commission , Head Of Corporate Communications , Globenewswire Inc , Arcutis Biotherapeutics Inc , Scalp Investigator Global Assessment , Body Investigator Global Assessment , Rial Employing , Arcutis Biotherapeutics , Nc Stock Exchange , Press Release , Ompared Arqt Us03969k1088 ,